Apogee Therapeutics, Inc. (APGE) NASDAQ
78.71
-0.59(-0.74%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
78.71
-0.59(-0.74%)
Currency In USD
| Market Cap | 4.58B |
| Enterprise Value | 4.46B |
| P/E Ratio | -19.97 |
| PEG Ratio | 1.08 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.37 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -14.89 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.21 |
| Return On Equity | -0.33 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.42M |
| EBITDA | -284.18M |
| Net Income | -255.84M |
| Diluted EPS | -4.22 |
| Total Cash | 1.06B |
| Total Cash/Share | 15.21 |
| Total Debt | 8.05M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 32.59 |
| Book Value Per Share | 18.03 |
| 52-Week Change | 116.65 |
| 52-Week High | 95.32 |
| 52-Week Low | 34.34 |
| Moving Average 50 Days | 83.32 |
| Moving Average 200 Days | 66.4 |
| Average Volume | 939,311 |
| Shares Outstanding | 61.9M |
| % Held by Institutions | 130.27 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |